Sequence variation in the 3′‐untranslated region of the dopamine transporter gene and attention‐deficit hyperactivity disorder (ADHD)
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The dopamine transporter gene (DAT1) has been reported to be associated with attention‐deficit hyperactivity disorder (ADHD) in a number of studies [Cook et al. (1995): Am J Human Genet 56(4):9993–998; Gill et al. (1997): Mol Psychiatry 2(4):311–313; Waldman et al. (1998): Am J Human Genet 63(6):1767–1776; Barr et al. (2001): Biol Psychiatry 49(4):333–339; Curran et al. (2001): Mol Psychiatry 6(4):425–428; Chen et al. (2003): Mol Psychiatry 8(4):393–396]. Specifically, the 10‐repeat allele of the 40‐bp variable number of tandem repeats (VNTR) polymorphism located in the 3′ untranslated region (UTR) of the gene has been found to be associated with ADHD. There is evidence from in vitro studies indicating that variability in the repeat number, and sequence variation in the 3′‐UTR of the DAT1 gene may influence the level of the dopamine transporter protein [Fuke et al. (2001): Pharmacogenomics J 1(2):152–156; Miller and Madras (2002): Mol Psychiatry 7(1):44–55]. In this study, we investigated whether DNA variation in the DAT1 3′UTR contributed to ADHD by genotyping DNA variants around the VNTR region in a sample of 178 ADHD families. These included a Msp I polymorphism (rs27072), a Dra I DNA change (T/C) reported to influence DAT1 expression levels, and a Bst UI polymorphism (rs3863145) in addition to the VNTR. We also screened the VNTR region by direct resequencing to determine if there was sequence variation within the repeat units that could account for the association. Our results indicate that DAT1 is associated with ADHD in our sample but not with alleles of the VNTR polymorphism. We did not find any variation in the sequence for either the 10‐ or 9‐repeat alleles in the probands screened nor did we observe the reported Dra I (T/C) variation. Our results therefore refute the possibility of the reported Dra I variation or alleles of the VNTR as the functional variants contributing to the disorder. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684 · cited 1×
“E-mail: cbarr@uhnres.utoronto.ca Received 9 September 2004; Accepted 22 November 2004 DOI 10.1002/ajmg.b.30190 2005 Wiley-Liss, Inc. the striatum [Dougherty et al., 1999; Krause et al., 2000; Cheon et al., 2003].”
InfluentialGenotype Influences In Vivo Dopamine Transporter Availability in Human Striatum
Heinz, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00099-8 · Cited by 538 · cited 3×
“Further, a number of imaging [Heinz et al., 2000; Jacobsen et al., 2000; Martinez et al., 2001] and pharmacogenetic studies [Winsberg and Comings, 1999; Roman et al.”
BackgroundMethodKrause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521 · cited 1×
“E-mail: cbarr@uhnres.utoronto.ca Received 9 September 2004; Accepted 22 November 2004 DOI 10.1002/ajmg.b.30190 2005 Wiley-Liss, Inc. the striatum [Dougherty et al., 1999; Krause et al., 2000; Cheon et al., 2003].”
InfluentialGill, M., Daly, G., Heron, S., Hawi, Z., & Fitzgerald, M. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000290 · Cited by 482
Waldman, I. D., Rowe, D. C., Abramowitz, A., Kozel, S. T., Mohr, J. H., Sherman, S. L., Cleveland, H. H., Sanders, M. L., Gard, J. M. C., & Stever, C. (1998) · The American Journal of Human Genetics · doi:10.1086/302132 · Cited by 462
Mill, J., Asherson, P., Browes, C., D'Souza, U., & Craig, I. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.b.10948 · Cited by 341 · cited 1×
“This idea is supported by the finding of a correlation between the number of 10-repeat alleles and increased DAT1 mRNA expression in the cerebellum, the temporal lobe, and in lymphocytes [Mill et al., 2002].”
Result
Cited by
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Brookes, K., Xu, X., Chen, W., Zhou, K., Neale, B., Lowe, N., Aneey, R., Franke, B., Gill, M., Ebstein, R., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001869 · Cited by 533
Yang, B., Chan, R. C. K., Jing, J., Li, T., Sham, P., & Chen, R. Y. L. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30453 · Cited by 175
Pinsonneault, J. K., Han, D. D., Burdick, K. E., Kataki, M., Bertolino, A., Malhotra, A. K., Gu, H. H., & Sadee, W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.45 · Cited by 147
“Of note, rs27072 has been implicated in ADHD (Feng et al, 2005; Ouellet-Morin et al, 2008), but evidence for a functional role of rs27072 is lacking.”
BackgroundResultInfluentialBurt, S. A., & Mikolajewski, A. J. (2008) · Aggressive Behavior · doi:10.1002/ab.20251 · Cited by 98
Metadata
- Authors
- Feng, Y., Wigg, K. G., Makkar, R., Ickowicz, A., Pathare, T., Tannock, R., Roberts, W., Malone, M., Kennedy, J. L., Schachar, R., & Barr, C. L.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2005-08-04
- Volume
- 139B
- Issue
- 1
- Pages
- 1-6
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2065999936
- Cited by
- 50
- References
- 6
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.